<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="5ddba454-f3e6-43c2-a7a6-58365d297213"><labelDrug name="Diovan"><Normalization><mmtx cui="C0719949" preferredWord="Diovan" semType="phsu, orch"/></Normalization></labelDrug><generic name="valsartan"/><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.1" text="DIOVAN (valsartan) tablet" type="negative"><entity charOffset="0:6" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.1.e.0" text="diovan" type="Biomedical_Entity"><Normalization><mmtx cui="C0719949" phraseText="DIOVAN" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="8:17" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.1.e.1" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="(valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.1.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.1.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4" lineNumber="7" text="Do not coadminister aliskiren with Diovan in patients with diabetes [See Drug Interactions (7)]." type="regular"><entity charOffset="0:19" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="20:29" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Diovan" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:41" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.3" text="Diovan" type="Drug"><Normalization><mmtx cui="C0719949" phraseText="aliskiren with Diovan" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="59:67" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.0"><relations><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.4" ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.3" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.4.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.15" text="In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. " type="negative"><entity charOffset="126:135" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.15.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="high doses of diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.15.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.15.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.15.e.0"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20" text="In the Valsartan in Acute Myocardial Infarction Trial (VALIANT), hypotension in post-myocardial infarction patients led to permanent discontinuation of therapy in 1.4% of valsartan-treated patients and 0.8% of captopril-treated patients." type="negative"><entity charOffset="171:180" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20.e.0" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="of valsartan-treated patients" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="7:16" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20.e.1" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="In the Valsartan in Acute Myocardial Infarction Trial (VALIANT)," preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="210:219" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20.e.2" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="0.8% of captopril-treated patients." preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20.e.2"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.20.e.2"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.24" text="Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. " type="negative"><entity charOffset="128:137" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.24.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="and by diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="102:113" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.24.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.24.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.24.e.0"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.25" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g. patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on Diovan. " type="negative"><entity charOffset="78:89" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.25.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="281:287" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.25.e.1" text="diovan" type="Biomedical_Entity"><Normalization><mmtx cui="C0719949" phraseText="on Diovan." preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.25.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.25.e.1"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34" text="No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. " type="negative"><entity charOffset="160:170" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="furosemide," preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="117:127" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="coadministered with amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="74:80" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" text="diovan" type="Biomedical_Entity"><Normalization><mmtx cui="C0719949" phraseText="Diovan" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="207:219" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3" text="indomethacin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021246" phraseText="indomethacin." preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="151:158" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="183:202" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="82:91" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="(valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="139:149" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="cimetidine," preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="172:181" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8" text="glyburide" type="Biomedical_Entity"><Normalization><mmtx cui="C0017628" phraseText="glyburide," preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="129:137" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="atenolol," preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.3"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.4"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.5"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.6" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.7"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.9" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.34.e.8"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35" lineNumber="35" text="The valsartan-atenolol combination was more antihypertensive than either component, but it did not lower the heart rate more than atenolol alone." type="regular"><entity charOffset="4:13" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.0" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="The valsartan-atenolol combination" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="14:22" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.1" text="atenolol" type="Drug"><Normalization><mmtx cui="C0004147" phraseText="The valsartan-atenolol combination" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><entity charOffset="39:60" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.2" text="more antihypertensive" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.1" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.35.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36" text="Coadministration of valsartan and warfarin did not change the pharmacokinetics of valsartan or the time-course of the anticoagulant properties of warfarin." type="negative"><entity charOffset="146:154" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="the time-course of the anticoagulant properties of warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="118:131" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.1" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="the time-course of the anticoagulant properties of warfarin." preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="34:42" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.2" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="20:29" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.3" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="Coadministration of valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="82:91" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.4" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="the pharmacokinetics of valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.3" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.4" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.0"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.3" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.4" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.3" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.2"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.36.e.4"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.37" text="CYP 450 Interactions: In vitro  metabolism studies indicate that CYP 450 mediated drug interactions between valsartan and coadministered drugs are unlikely because of the low extent of metabolism [see Clinical Pharmacology (12.3)]." type="negative"><entity charOffset="73:81" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.37.e.0" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="that CYP 450 mediated drug interactions between valsartan" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><entity charOffset="108:117" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.37.e.1" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="that CYP 450 mediated drug interactions between valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.37.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.37.e.1"/></sentence><sentence biomedicalEntities="6" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39" lineNumber="41" text="Coadministration of inhibitors of the uptake transporter (rifampin, cyclosporine) or efflux transporter (ritonavir) may increase the systemic exposure to valsartan." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.38" Text="Transporters: The results from an in vitro study with human liver tissue indicate that valsartan is a substrate of the hepatic uptake transporter OATP1B1 and the hepatic efflux transporter MRP2. "/><anaphoraEntity charOffset="38:56" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.1" text="uptake transporter" type="Expression"/><antecedentEntity charOffset="119:153" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.38.e.0" text="hepatic uptake transporter OATP1B1" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.38" Text="Transporters: The results from an in vitro study with human liver tissue indicate that valsartan is a substrate of the hepatic uptake transporter OATP1B1 and the hepatic efflux transporter MRP2. "/><anaphoraEntity charOffset="85:103" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.4" text="efflux transporter" type="Expression"/><antecedentEntity charOffset="162:193" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.38.e.1" text="hepatic efflux transporter MRP2" type="SPAN"/></anaphoraRelation><entity charOffset="20:56" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.0" text="inhibitors of the uptake transporter" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="20:37|85:103" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.3" text="inhibitors of the efflux transporter" type="Drug_Class"><Normalization><mmtx cui="C0035608" phraseText="(rifampin," preferredWord="Rifampin" semType="orch, antb"/><mmtx cui="C0010592" phraseText="cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="58:66" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.6" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="(rifampin," preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="68:80" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.8" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="105:114" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.10" text="ritonavir" type="Drug"><Normalization><mmtx cui="C0292818" phraseText="(ritonavir" preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="120:150" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.12" text="increase the systemic exposure" type="Increase_Interaction"/><entity charOffset="154:163" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.14" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="the systemic exposure to valsartan." preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.6" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.0"/><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.8" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.0"/><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.10" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.3"/><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.14"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.3" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.14" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.12" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.14" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.12" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.39.e.3"/></sentence><sentence biomedicalEntities="8" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40" lineNumber="43" text="Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium sparing diuretics (e.g. spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. " type="regular"><entity charOffset="30:39" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="Concomitant use of valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="51:97" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1" text="agents that block the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="with other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the renin-angiotensin system," preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="99:126" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2" text="potassium sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="133:147" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.3" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="e.g. spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="149:160" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.4" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="162:171" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.5" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="174:195" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="200:237" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="250:278" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.11" text="increases in serum potassium" type="Specific_Interaction"/><entity charOffset="312:341" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.13" text="increases in serum creatinine" type="Specific_Interaction"/><entity charOffset="286:299" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.15" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="and in heart failure patients" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="and in heart failure patients" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.3" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2"/><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.4" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2"/><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.5" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2"/><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.11"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.ddi.2"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.13"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.15"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.11" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.11" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.11" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.11" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.41" lineNumber="43" text="If co-medication is considered necessary, monitoring of serum potassium is advisable." type="irregular"><entity charOffset="42:52" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.41.e.0" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.41.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.41.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40" text="Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium sparing diuretics (e.g. spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. "><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.10"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40" text="Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium sparing diuretics (e.g. spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. "><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.9"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40" text="Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium sparing diuretics (e.g. spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. "><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40" text="Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium sparing diuretics (e.g. spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. "><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40" text="Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium sparing diuretics (e.g. spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. "><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.40.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42" lineNumber="45" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including valsartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="127:134" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.0" text="elderly" type="SPAN"/><entity charOffset="136:151" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="199:225" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="247:253" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="coadministration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="265:291" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="298:333" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.6" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="345:354" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.7" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="valsartan," preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="370:401" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="422:441" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.4"/><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.7" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.6"/><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.9"><relations><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.ddi.2"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.11"><relations><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.6"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.2, Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.1, Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.0" ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.3" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.6" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.42.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44" lineNumber="45" text="Monitor renal function periodically in patients receiving valsartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:67" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.2" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="72:77" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.3" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.44.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45" lineNumber="47" text="The antihypertensive effect of angiotensin II receptor antagonists, including valsartan may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.0" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:87" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.1" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="109:115" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="126:152" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="4:27|95:105" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.6" text="antihypertensive effect attenuated" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.1" drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.0"/><classClassMembership drugClass="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.4"/><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.3" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46" lineNumber="49" text="Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="83:112" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="114:128" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="133:142" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="181:192" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="194:206" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="212:237" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="249:268" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45" text="The antihypertensive effect of angiotensin II receptor antagonists, including valsartan may be attenuated by NSAIDs including selective COX-2 inhibitors."><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.ddi.2"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45" text="The antihypertensive effect of angiotensin II receptor antagonists, including valsartan may be attenuated by NSAIDs including selective COX-2 inhibitors."><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.ddi.3"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45" text="The antihypertensive effect of angiotensin II receptor antagonists, including valsartan may be attenuated by NSAIDs including selective COX-2 inhibitors."><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.ddi.4"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45" text="The antihypertensive effect of angiotensin II receptor antagonists, including valsartan may be attenuated by NSAIDs including selective COX-2 inhibitors."><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.45.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.46.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47" lineNumber="49" text="Closely monitor blood pressure, renal function and electrolytes in patients on Diovan and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:85" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.2" text="Diovan" type="Drug"><Normalization><mmtx cui="C0719949" phraseText="on Diovan" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="96:122" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the RAS." preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the RAS." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.3" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.47.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48" lineNumber="51" text="Do not coadminister aliskiren with Diovan in patients with diabetes. " type="regular"><entity charOffset="0:19" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="20:29" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Diovan" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:41" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.3" text="Diovan" type="Drug"><Normalization><mmtx cui="C0719949" phraseText="aliskiren with Diovan" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="59:67" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.0"><relations><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.4" ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.3" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.48.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49" lineNumber="51" text="Avoid use of aliskiren with Diovan in patients with renal impairment (GFR &lt;60 mL/min)." type="regular"><entity charOffset="0:5" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:34" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.3" text="Diovan" type="Drug"><Normalization><mmtx cui="C0719949" phraseText="with Diovan" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="52:68" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.ddi.1"><interaction trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.4" ddi="true" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.3" trigger="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.49.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.54" text="In post-myocardial infarction patients, doubling of serum creatinine was observed in 4.2% of valsartan-treated patients and 3.4% of captopril-treated patients." type="negative"><entity charOffset="132:141" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.54.e.0" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="3.4% of captopril-treated patients." preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><entity charOffset="93:102" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.54.e.1" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="observed in 4.2% of valsartan-treated patients" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.54.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.54.e.0"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60" text="Serum Potassium: In hypertensive patients, greater than 20% increases in serum potassium were observed in 4.4% of Diovan-treated patients compared to 2.9% of placebo-treated patients. " type="negative"><entity charOffset="6:15" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Serum Potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="114:120" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60.e.1" text="diovan" type="Biomedical_Entity"><Normalization><mmtx cui="C0719949" phraseText="observed in 4.4% of Diovan-treated patients" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="79:88" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="in serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.60.e.1"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.61" text="In heart failure patients, greater than 20% increases in serum potassium were observed in 10.0% of Diovan-treated patients compared to 5.1% of placebo-treated patients." type="negative"><entity charOffset="99:105" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.61.e.0" text="diovan" type="Biomedical_Entity"><Normalization><mmtx cui="C0719949" phraseText="observed in 10.0% of Diovan-treated patients" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="63:72" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.61.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="in serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.61.e.1" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.61.e.0"/></sentence><sentence id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62" text="Blood Urea Nitrogen (BUN): In heart failure trials, greater than 50% increases in BUN were observed in 16.6% of Diovan-treated patients compared to 6.3% of placebo-treated patients." type="negative"><entity charOffset="82:85" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62.e.0" text="bun" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="in BUN" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="221770"/></Normalization></entity><entity charOffset="112:118" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62.e.1" text="diovan" type="Biomedical_Entity"><Normalization><mmtx cui="C0719949" phraseText="observed in 16.6% of Diovan-treated patients" preferredWord="Diovan" semType="phsu, orch"/><RxNorm RxCui="216652"/></Normalization></entity><entity charOffset="6:10" id="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62.e.2" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="Blood Urea Nitrogen (BUN)" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62.e.0" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62.e.1"/><pair ddi="false" e1="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62.e.2" e2="Dailymed.5ddba454-f3e6-43c2-a7a6-58365d297213.s.62.e.1"/></sentence><positiveExamples number="20"/><negativeExamples number="77"/></document>